Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient

American Journal of Infection Control

Volumn 39, Issue 3, 2011, Pages 247-249

  Bernstein, Paul ^a   Furuya, Yoko ^b   Steinberg, Sharon ^b   Scully, Brian ^b   Larussa, Philip ^b   Gershon, Anne A ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Immunocompetent; infection control; polymerase chain reaction; rash; vaccine

Indexed keywords

HERPES ZOSTER IMMUNOGLOBULIN; VALACICLOVIR; VARICELLA ZOSTER VACCINE;

ADULT; ANTIBODY TITER; ANTIVIRAL THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BLOOD SAMPLING; CASE REPORT; COUGHING; DIARRHEA; DRUG ERUPTION; DYSPNEA; FEMALE; FEVER; HERPES ZOSTER; HOSPITAL PATIENT; HUMAN; IMMUNOFLUORESCENCE TEST; MITRAL VALVE REPLACEMENT; NAUSEA; PATIENT CARE; POLYMERASE CHAIN REACTION; PROTEUS INFECTION; PROTEUS MIRABILIS; REGISTERED NURSE; URINE CULTURE; UROSEPSIS; VACCINATION; VARICELLA ZOSTER VIRUS; VESICULAR RASH; VOMITING;

ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; EXANTHEMA; FEMALE; HEALTH PERSONNEL; HERPESVIRUS 3, HUMAN; HUMANS; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POST-EXPOSURE PROPHYLAXIS;

EID: 79953647515     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.06.027     Document Type: Article

References (14)

1. Gershon AA, Steinberg SP, LaRussa P, Ferara A, Hammerschlag M, Gelb L. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988;158:132-7.
2. Hardy IR, Gershon AA. Prospects for use of a varicella vaccine in adults. Infect Dis Clin North Am 1990;4:159-73.
3. Marin M, Guris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56(RR-4):1-40.
4. Marin M, Watson T, Chaves S, Civen R, Watson B, Zhang J, et al. Varicella among adults: data from an active surveillance project, 1995-2005. J Infect Dis 2008;197:S94-100.
5. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg S, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 1992;66:1016-20.
6. Grossberg R, Harpaz R, Rubtcova E, Loparev V, Seward J, Schmid D. Secondary transmission of varicella vaccine virus in a chronic care facility for children. J Pediatr 2006;148:842-4. (Pubitemid 43870088)
7. Hambleton S, Gershon AA. Preventing varicella-zoster disease. Clin Micro Rev 2005;18:70-80. (Pubitemid 40170661)
8. Krasinski K, Holzman R, La Couture R, Florman AL. Hospital experience with varicella-zoster virus. Infect Control 1986;7:312-6. (Pubitemid 16024708)
9. Gallagher J, Quaid B, Cryan B. Susceptibility to varicella-zoster virus infection in health care workers. Occup Med 1996;46:289-92. (Pubitemid 26302361)
10. Saiman L, LaRussa P, Steinberg S, Zhou J, Baron K, Whittier S, et al. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Infect Control Hosp Epidemiol 2001;22:279-83. (Pubitemid 32550273)
11. Gershon A. Varicella-zoster virus: prospects for control. In: Arnoff SC, Hughes WT, Wald ER, Kohl S, Speck WT, eds. Advances in pediatric infectious diseases, vol. 10. St Louis: Mosby; 1995. p. 93-124.
12. Sauerbrei A,Wutzler P. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol 2006;44:3094-7.
13. Tsolia M, Gershon AA, Steinberg S, Gelb L, NIAID Varicella Vaccine Collaborative Study Group. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. J Pediatr 1990;116:184-9. (Pubitemid 20056770)
14. LaRussa P, Steinberg S, Meurice F, Gershon A. Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts. J Infect Dis 1997;176:1072-5. (Pubitemid 27411054)